EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum immune markers and transition to psychosis in individuals at clinical high risk

Valeria Mondelli, Graham Blackman, Matthew J Kempton, Thomas A Pollak, Conrad Iyegbe, Lucia R Valmaggia, Paul Amminger, Neus Barrantes-Vidal, Rodrigo Bressan, Mark van der Gaag, Lieuwe de Haan, Marie-Odile Krebs und 8 weitere

Brain, Behavior, and Immunity · 2023

DOI: 10.1016/j.bbi.2023.03.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2023. Verfasst von Valeria Mondelli und 19 weiteren Autor:innen. Beteiligte Einrichtung: King's College London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, London, UK; National Institute for…. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Psychotic Disorders. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals at clinical high risk (CHR) for psychosis have been found to have altered cytokine levels, but whether these changes are related to clinical outcomes remains unclear. We addressed this issue by measuring serum levels of 20 immune markers in 325 participants (n = 269 CHR, n = 56 healthy controls) using multiplex immunoassays, and then followed up the CHR sample to determine their clinical outcomes. Among 269 CHR individuals, 50 (18.6 %) developed psychosis by two years. Univariate and machine learning techniques were used to compare levels of inflammatory markers in CHR subjects and healthy controls, and in CHR subjects who had (CHR-t), or had not (CHR-nt) transitioned to psychosis. An ANCOVA identified significant group differences (CHR-t, CHR-nt and controls) and post-hoc tests indicated that VEGF levels and the IL-10/IL-6 ratio were significantly higher in CHR-t than CHR-nt, after adjusting for multiple comparisons. Using a penalised logistic regression classifier, CHR participants were distinguished from controls with an area-under the curve (AUC) of 0.82, with IL-6 and IL-4 levels the most important discriminating features. Transition to psychosis was predicted with an AUC of 0.57, with higher VEGF level and IL-10/IL-6 ratio the most important discriminating features. These data suggest that alterations in the levels of peripheral immune markers are associated with the subsequent onset of psychosis. The association with increased VEGF levels could reflect altered blood-brain-barrier (BBB) permeability, while the link with an elevated IL-10/IL-6 ratio points to an imbalance between anti- and pro-inflammatory cytokines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor APsychotic DisordersHumansInterleukin-10Interleukin-6BiomarkersCytokines

Stichwörter der Autor:innen

Clinical high riskCytokinesImmune markersInflammationInterleukin-6PsychosisTransitionVEGF

Substanzen

Vascular Endothelial Growth Factor AInterleukin-10Interleukin-6BiomarkersCytokines

Autor:innen und Institutionen

  • King's College London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, London, UK; National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre a…
  • National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK; King's College London, Institute of Psychiatry,…
  • King's College London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, London, UK.
  • Centre for Youth Mental Health, University of Melbourne, 35 Poplar Road (Locked Bag 10), Parkville, Victoria 485 3052, Australia.
  • Departament de Psicologia Clínica i de la Salut (Universitat Autònoma de Barcelona), Fundació Sanitària Sant Pere Claver (Spain), Spanish Mental Health Research Network (CIBERSAM), Australia.
  • LiNC - Lab Interdisciplinar Neurociências Clínicas, Depto Psiquiatria, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP), Australia.

Förderung

  • Medical Research Council

Zitieren

APA

Mondelli, V., Blackman, G., Kempton, M. J., Pollak, T. A., Iyegbe, C., Valmaggia, L. R., Amminger, P., Barrantes-Vidal, N., Bressan, R., van der Gaag, M., de Haan, L., Krebs, M. O., Nordentoft, M., Ruhrmann, S., Riecher-Rössler, A., Rutten, B. P. F., Sachs, G., Koutsouleris, N., EU GEI High Risk Study, & McGuire, P. (2023). Serum immune markers and transition to psychosis in individuals at clinical high risk. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2023.03.014

Vancouver

Mondelli V, Blackman G, Kempton MJ, Pollak TA, Iyegbe C, Valmaggia LR, et al. Serum immune markers and transition to psychosis in individuals at clinical high risk. Brain, Behavior, and Immunity. 2023. doi:10.1016/j.bbi.2023.03.014

BibTeX
@article{Mondelli2023,
  author = {Mondelli, Valeria and Blackman, Graham and Kempton, Matthew J and Pollak, Thomas A and Iyegbe, Conrad and Valmaggia, Lucia R and Amminger, Paul and Barrantes-Vidal, Neus and Bressan, Rodrigo and van der Gaag, Mark and de Haan, Lieuwe and Krebs, Marie-Odile and Nordentoft, Merete and Ruhrmann, Stephan and Riecher-Rössler, Anita and Rutten, Bart P F and Sachs, Gabriele and Koutsouleris, Nikolaos and EU GEI High Risk Study, EU GEI High Risk Study and McGuire, Philip},
  title = {Serum immune markers and transition to psychosis in individuals at clinical high risk},
  journal = {Brain, Behavior, and Immunity},
  year = {2023},
  doi = {10.1016/j.bbi.2023.03.014}
}
Kostenlos starten →